- Company Details
The androgen receptor (AR) remains a key therapeutic target for prostate cancer (PCa), even in castration resistant PCa (CRPC). Current therapies target AR by blocking androgen synthesis or competiti ...SBIRPhase I2011Department of Health and Human Services
ARTA BIOSCIENCE, INC.
SAINT LOUIS, MO, 63105-2272
|# of Employees:||0|
|Socially and Economically Disadvantaged:||N|